| Literature DB >> 36236133 |
D S Abdullah Al Maruf1,2, Yohaann Ali Ghosh1,2, Hai Xin1,2, Kai Cheng3, Payal Mukherjee1,3, Jeremy Micah Crook4,5,6,7,8,9, Gordon George Wallace7,8, Travis Jacob Klein10, Jonathan Robert Clark1,2,3.
Abstract
Free flap surgery is currently the only successful method used by surgeons to reconstruct critical-sized defects of the jaw, and is commonly used in patients who have had bony lesions excised due to oral cancer, trauma, infection or necrosis. However, donor site morbidity remains a significant flaw of this strategy. Various biomaterials have been under investigation in search of a suitable alternative for segmental mandibular defect reconstruction. Hydrogels are group of biomaterials that have shown their potential in various tissue engineering applications, including bone regeneration, both through in vitro and in vivo pre-clinical animal trials. This review discusses different types of hydrogels, their fabrication techniques, 3D printing, their potential for bone regeneration, outcomes, and the limitations of various hydrogels in preclinical models for bone tissue engineering. This review also proposes a modified technique utilizing the potential of hydrogels combined with scaffolds and cells for efficient reconstruction of mandibular segmental defects.Entities:
Keywords: 3D printing; bone tissue engineering; hydrogel; mandibular defect; scaffolds
Year: 2022 PMID: 36236133 PMCID: PMC9571534 DOI: 10.3390/polym14194186
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Figure 1Actions of osteoclasts, osteoblasts and bone lining cells in the context of a segmental mandibular defect. Selected molecular mechanisms of regulation between osteoblasts and osteoclasts include BMP6, WNT10B, SEMA4D, CT-1, M-CSF, RANKL, and WNT5A.
Figure 2Proposed classification of mandibular defects. Mean defect size (dark shading); total extent of mandibular defect (light shading). Reprinted with permission from Elsevier [30].
Figure 3(A,B) Three-dimensional mandibular resection and design of the mandibular resection guide for a patient with intra-osseous carcinoma of the mandible, using the virtual surgical planning software. (C) Virtual planning of the fibular inset. (D,E) Automatic virtual planning of fibula flap length, osteotomy angle, and osteotomy guide. (F) Virtual planning of the mandibular reconstruction template Reprinted with permission from Elsevier [44].
Figure 4Non-vascularised iliac bone graft adapted to premolded reconstructing plate. Reprinted with permission from [45].
Figure 5(a) Schematic of SLA 3D printer. (b) SLA printed hydrogel cantilevers with different molecular weight (700/3400 Da) of PEGDA. Scale bar, 1 mm. (c) SLA printed hydrogel buckyball and valve at different condition. Scale bar, 2 cm. Reprinted with permission from Elsevier [152].
Figure 6(a) Schematic of extrusion-based 3D printers. (b) Reversible gel-sol transition of particular gel-based ink under cyclic shearing strains of 1% (G′ > G″) and 10% (G′ < G″). (c) i. A rat-size thigh-bone and ii. a human-size ear model fabricated by extrusion-based 3D printing. Reprinted with permission from Elsevier [152].
Figure 7(a) Schematic of inkjet-based 3D printer. (b) Model and confocal slices at relative positions of a inkjet-based 3D printed microvasculature. Scale bar, 200 µm. (c) Micropatterned conducting hydrogel by inkjet-based 3D printing. Reprinted with permission from Elsevier [152].
Applications of different hydrogels in various in vitro and in vivo bone regeneration studies.
| Base Material/s | Modification (Reference) | Control | Aim of Modification | In Vitro or In Vivo (Model Used) | Outcomes Achieved | Comment/Evidence |
|---|---|---|---|---|---|---|
| Alginate-Gelatin | Bioactive glass [ | Alginate only | Osteogenesis | In vitro | Osteogenic differentiation with/without bioactive glass in absence of osteogenic stimulants | Osteogenic supplement is essential for upregulating gene expression. |
| Oxidized | RGD grafting [ | Hydrogel without cells | Reduce hydrophilicity+ | In vitro | Slow degradation | Lack of gene expression data for both endothelial and osteogenic differentiation. |
| Glycol-chitosan-Hyaluronic acid | Nano-HA [ | - | Increase the enzymatic degradation | In vitro | Porous scaffold | No information on cellular proliferation, osteogenic differentiation, mechanical strength of the scaffold. |
| Methacrylated glycol chitosan (MeGC) | Collagen [ | MeGC only | Increase strength | In vitro | Increased compressive strength | Long-term in vitro study is required to evaluate the degradability and osteogenic gene expression beyond the 21 days. |
| Titanium | Surface coating with GelMA and HA [ | Titanium only | Improved osseointegration | In vitro | Enhanced osseointegration claimed | Appropriate model required for evaluating osseointegration |
| GelMA | Poly(ethylene glycol) diacrylate (PEGDA), acryloyl-6-aminocaproic acid (A6ACA) and calcium phosphate [ | Non-mineralized GelMA | Osteogenic differentiation | In vitro | Osteogenic differentiation of hiPSCs | Evidence: Low |
| GelMA | Gold nanoparticles [ | GelMA only and blank control | Enhance osteogenesis | In vitro | ADSC proliferation | Study in load-bearing bone is required. |
| Alginate-gelatin- Nano-HA | PCL scaffold [ | Hydrogel-loaded PCL scaffold without cells | Osteogenesis | In vitro | Mineralisation (apatite) | Evidence: Low |
| Alginate | Beta-tricalcium phosphate (β-TCP) [ | None | Osteogenic differentiation | In vitro | Improved compressive strength with higher concentration of alginate (2% vs. 1%) | Cellular behaviour such as cell viability, proliferation in response to the hydrogel system has not been tested |
| Chitosan/β-glycerophosphate | Collagen Type I [ | Uncoated group for in vitro study and Chitosan/β-glycerophosphate only for In vivo study | Reduces β-glycerophosphate related toxicity | In vitro (Mouse-derived green fluorescent protein-labelled MSCs) | Good biocompatibility | Bone defect model required. |
| Gels based on glyco-nucleo-lipids containing a fluorinated carbon chain (GNF) | Collagen type I [ | GNF only | Osteogenesis | Both in vitro (hADSCs) and in vivo | Improves the biological properties of the hydrogel as cell culture support | Bone defect model required. |
| Carboxymethyl chitosan (CMCh) | amorphous calcium phosphate (ACP) [ | Without the CMCh-ACP hybrid gel | Osteogenesis | Both in vitro (BMP-9 induced Human HEK-293 cells) and in vivo | Osteoinduction | Evidence: Medium |
| Peptide-modified alginate | Bone morphogenetic protein-2 (BMP-2) [ | Nano-fiber mesh without alginate and BMP-2 | Osteoinduction | In vivo | Improved bone volume and bone density | Evidence: Medium |
| Chondroitin sulphate and maleimido terminated polyethylene glycol (PEG-AMI) | BMP-4 [ | Blank and hydrogel only | Osteoinduction | In vivo | Defect repaired by new bone tissue | Load-bearing bone defect in large animal model required. |
| PEG-PCL-PEG copolymer, and collagen | Nano-HA [ | Blank control | Osteoinduction | In vivo | Osteogenesis | Load-bearing bone model required. |
| Silk nanofiber (SNF) | HA nano particles [ | Cell only for in vitro and SF for in vivo study | Osteogenesis | Both in vitro (rat BMSCs (rBMSCs) and in vivo | Good cellular response to the hydrogel | HA played a vital role in forming new bone tissue. |
| Silk nanofibers and HA | Deferoxamine (DFO) and BMP-2 [ | Blank control and SNF/HA only | Neovascularization | Both in vitro (rBMSCs) and in vivo | Progressive bone growth in the periphery of the defect | Require large animal model |
Evidence Definition: Very Low—no effect; Low—Effect demonstrated by single study in vitro, Medium—multiple studies in vitro or single study in vivo, High—multiple studies in vitro and single study in vivo, Very high—effect demonstrated by multiple studies in vivo.
Figure 8Combination of scaffold made of different biomaterials and hydrogel containing stem cells, and growth factors to repair a segmental mandibular defect.
Figure 9Application of hydrogel, stem cells, and growth factors to create customized ectopic bone with a goal to repair a segmental mandibular defect.